Melissa Tjota to Mutation
This is a "connection" page, showing publications Melissa Tjota has written about Mutation.
Connection Strength
0.451
-
Real world predictors of response and 24-month survival in high-grade TP53-mutated myeloid neoplasms. Blood Cancer J. 2024 06 18; 14(1):99.
Score: 0.105
-
Clinical Utility and Benefits of Comprehensive Genomic Profiling in Cancer. J Appl Lab Med. 2024 01 03; 9(1):76-91.
Score: 0.102
-
Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case. Pathology. 2021 Oct; 53(6):790-793.
Score: 0.083
-
TSC/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+/CK20-/vimentin-: a validation study. Hum Pathol. 2021 09; 115:84-95.
Score: 0.082
-
Eosinophilic Renal Cell Tumors With a TSC and MTOR Gene Mutations Are Morphologically and Immunohistochemically Heterogenous: Clinicopathologic and Molecular Study. Am J Surg Pathol. 2020 07; 44(7):943-954.
Score: 0.080